1. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R. Updated clinical classification of pulmonary hypertension.
J Am Coll Cardiol 62:2013;D34–D41.
2. Bolignano D, Rastelli S, Agarwal R, Fliser D, Massy Z, Ortiz A, Wiecek A, Martinez-Castelao A, Covic A, Goldsmith D, Suleymanlar G, Lindholm B, Parati G, Sicari R, Gargani L, Mallamaci F, London G, Zoccali C. Pulmonary hypertension in CKD.
Am J Kidney Dis 61:2013;612–622.
3. Sise ME, Courtwright AM, Channick RN. Pulmonary hypertension in patients with chronic and end-stage kidney disease.
Kidney Int 84:2013;682–692.
4. Akmal M, Barndt RR, Ansari AN, Mohler JG, Massry SG. Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy.
Kidney Int 47:1995;158–163.
5. Amin M, Fawzy A, Hamid MA, Elhendy A. Pulmonary hypertension in patients with chronic renal failure: role of parathyroid hormone and pulmonary artery calcifications.
Chest 124:2003;2093–2097.
6. Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, Bayturan O, Dinc G. Pulmonary hypertension in patients with chronic renal failure.
Respiration 74:2007;503–510.
7. Kumbar L, Fein PA, Rafiq MA, Borawski C, Chattopadhyay J, Avram MM. Pulmonary hypertension in peritoneal dialysis patients.
Adv Perit Dial 23:2007;127–131.
8. Nakhoul F, Yigla M, Gilman R, Reisner SA, Abassi Z. The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access.
Nephrol Dial Transplant 20:2005;1686–1692.
9. Abdelwhab S, Elshinnawy S. Pulmonary hypertension in chronic renal failure patients.
Am J Nephrol 28:2008;990–997.
10. Kim SC, Kim HW, Oh SW, Yang HN, Kim MG, Jo SK, Cho WY, Kim HK. Low iPTH can predict vascular and coronary calcifications in patients undergoing peritoneal dialysis.
Nephron Clin Pract 117:2011;c113–c119.
11. Oh SW, Cha JJ, Yang HN, Jo SK, Kim HK. A low intact PTH is associated with simple vascular calcifications in hemodialysis patients. Kidney Res Clin Pract 30:2011;260–268.
12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, John Sutton M, Stewart W. Recommendations for chamber quantification.
Eur J Echocardiogr 7:2006;79–108.
13. Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Goncalves M, Negrao AP. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.
Nephrol Dial Transplant 19:2004;1480–1488.
14. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
Am J Kidney Dis 42:2003;S1–S201.
15. Yigla M, Fruchter O, Aharonson D, Yanay N, Reisner SA, Lewin M, Nakhoul F. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients.
Kidney Int 75:2009;969–975.
16. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).
Eur Heart J 30:2009;2493–2537.
17. Karohl C, D’Marco Gascon L, Raggi P. Noninvasive imaging for assessment of calcification in chronic kidney disease.
Nat Rev Nephrol 7:2011;567–577.
18. Shroff R, Long DA, Shanahan C. Mechanistic insights into vascular calcification in CKD.
J Am Soc Nephrol 24:2013;179–189.
19. Cirit M, Ozkahya M, Cinar CS, Ok E, Aydin S, Akcicek F, Dorhout Mees EJ. Disappearance of mitral and tricuspid regurgitation in haemodialysis patients after ultrafiltration.
Nephrol Dial Transplant 13:1998;389–392.
20. Unal A, Sipahioglu M, Oguz F, Kaya M, Kucuk H, Tokgoz B, Buyukoglan H, Oymak O, Utas C. Pulmonary hypertension in peritoneal dialysis patients: prevalence and risk factors.
Perit Dial Int 29:2009;191–198.
21. Agarwal R. Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients.
Nephrol Dial Transplant 27:2012;3908–3914.
22. Li Z, Liu S, Liang X, Wang W, Fei H, Hu P, Chen Y, Xu L, Li R, Shi W. Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients.
Int Urol Nephrol 46:2014;141–149.
23. Clarkson MR, Giblin L, Brown A, Little D, Donohoe J. Reversal of pulmonary hypertension after ligation of a brachiocephalic arteriovenous fistula.
Am J Kidney Dis 40:2002;E8.
24. Lu KC, Wu CC, Yen JF, Liu WC. Vascular calcification and renal bone disorders.
Scientific World Journal 2014:2014;637065.